Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population
This is the largest national cohort study on mortality risk in CS over the past 2 decades, showing a significantly higher risk compared to matched controls in a homogeneous database. While etiology had no impact, remission significantly affected mortality, highlighting the importance of disease control for long-term survival.
Authors
- Shiri Kushnir (ORCID: https://orcid.org/0000-0003-2359-5249)
- Yaron Rudman (ORCID: https://orcid.org/0000-0003-3220-6321)
- Tzippy Shochat (ORCID: https://orcid.org/0000-0002-7576-8327)
- Maria Fleseriu (ORCID: https://orcid.org/0000-0001-9284-6289)
- Amit Akirov (ORCID: https://orcid.org/0000-0002-9376-344X)
- Hiba Masri‐Iraqi (ORCID: https://orcid.org/0000-0002-0889-8025)
- Ilan Shimon (ORCID: https://orcid.org/0000-0002-9188-3894)
Institutions
- Tel Aviv University (IL)
- Oregon Health & Science University (US)
- Rabin Medical Center (IL)
- Institute of Endocrinology (CZ)
- Neurological Surgery (US)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1093/ejendo/lvaf059
- Citations
- 8
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 10.36